microdose glp-1 menopause How microdosing drugs became a wellness 'craze' GLP-1 Microdosing During Menopause: Is

If you have the potential to become pregnant, discuss your birth control plans with your clinician before starting treatment

Personalized microbiome interventions are becoming more practical as sequencing costs decrease

Compared to sulfonylureas and metformin, liraglutide demonstrates advantages in glycemic control (assessed by HbA1c levels) and reduction of liver fat content (LFC) in patients with MASLD and T2DM, with a more significant difference observed over sulfonylureas

One of the most striking shifts is a move away from sheer quantity toward perceived quality

This evolving landscape is further complicated by the body positivity movement, which challenges traditional pathologizing frameworks and advocates for a broader appreciation of body diversity and health beyond BMI